Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: A molecular autopsy of 49 medical examiner/coroner's cases

Mayo Clinic Proceedings

Volumn 79, Issue 11, 2004, Pages 1380-1384

  Tester, David J ^a   Spoon, Daniel B ^b   Valdivia, Hector H ^c   Makielski, Jonathan C ^c   Ackerman, Michael J ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GENOMIC DNA; RYANODINE RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; COHORT ANALYSIS; CONTROLLED STUDY; CORONER; DNA SEQUENCE; EXON; FAMILY HISTORY; FEMALE; GENE MUTATION; HEART ARREST; HEART VENTRICLE TACHYCARDIA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEDICAL EXPERT; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PATHOGENESIS; POLYMERASE CHAIN REACTION; SUDDEN DEATH; SYNCOPE;

EID: 7544230111     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.11.1380     Document Type: Article

References (24)

1. Liberthson RR. Sudden death from cardiac causes in children and young adults. N Engl J Med. 1996;334:1039-1044.
2. Morentin B, Suarez-Mier MP, Aguilera B. Sudden unexplained death among persons 1-35 years old. Forensic Sci Int. 2003;135:213-217.
3. Wever EF, Robles de Medina EO. Sudden death in patients without structural heart disease. J Am Coll Cardiol. 2004;43:1137-1144.
4. Chugh SS, Kelly KL, Titus JL. Sudden cardiac death with apparently normal heart. Circulation. 2000;102:649-654.
5. Ackerman MJ. Cardiac channelopathies: it's in the genes. Nat Med. 2004;10:463-464.
6. Ackerman MJ, Tester DJ, Porter CJ, Edwards WD. Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning. N Engl J Med. 1999;341:1121-1125.
7. Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M. Brugada syndrome and sudden cardiac death in children [letter]. Lancet. 2000;355:808-809.
8. Ackerman MJ, Tester DJ, Driscoll DJ. Molecular autopsy of sudden unexplained death in the young. Am J Forensic Med Pathol. 2001 ;22:105-111.
9. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA. 2001;286:2264-2269.
10. Chugh SS, Senashova O, Watts A, et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol. 2004;43:1625-1629.
11. Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69-74.
12. Priori SG, Napolitano C, Tiso N, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation. 2001;103:196-200.
13. Laitinen PJ, Brown KM, Piippo K, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation. 2001;103:485-490.
14. Lahat H, Eldar M, Levy-Nissenbaum E, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation. 2001;103:2822-2827.
15. Eldar M, Pras E, Lahat H, A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia. Trends Cardiovasc Med. 2003;13:148-151.
16. Behr E, Wood DA, Wright M, et al, Sudden Arrhythmic Death Syndrome Steering Group. Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome. Lancet. 2003;362:1457-1459.
17. Lee A, Ackerman MJ. Sudden unexplained death: evaluation of those left behind. Lancet. 2003;362:1429-1430.
18. Bauce B, Rampazzo A, Basso C, et al. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers. J Am Coll Cardiol. 2002;40:341-349.
19. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet. 2001;10:189-194.
20. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003;78:1479-1487.
21. Di Paolo M, Luchini D, Bloise R, Priori SG. Postmortem molecular analysis in victims of sudden unexplained death. Am J Forensic Med Pathol. 2004;25:182-184.
22. Priori SG, Barhanin J, Hauer RN, et al. Genetic and molecular basis of cardiac arrhythmias: impact on clinical management. Eur Heart J. 1999;20:174-195.
23. Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation. 2004;110:2119-2124.
24. Cohle SD, Sampson BA. The negative autopsy: sudden cardiac death or other? Cardiovasc Pathol. 2001;10:219-222.